News & Updates

Selective autotaxin inhibition shows promise in diffuse cutaneous systemic sclerosis
Selective autotaxin inhibition shows promise in diffuse cutaneous systemic sclerosis
23 May 2023

The selective autotaxin inhibitor ziritaxestat shows therapeutic potential in patients with early diffuse cutaneous systemic sclerosis, conferring greater reductions in modified Rodnan skin score compared with placebo and potentially reducing fibrosis, according to data from the phase IIa NOVESA study.

Selective autotaxin inhibition shows promise in diffuse cutaneous systemic sclerosis
23 May 2023
Rheumatologists need to match patient’s health literacy, says study
Rheumatologists need to match patient’s health literacy, says study
22 May 2023

Communication between physicians and patients with systemic lupus erythematosus (SLE) leaves a lot to be desired, with a recent study suggesting that rheumatologists must beef up communication to match the health literacy (HL) of their patients. Doing so may foster trust and improve self-management and outcomes in SLE.

Rheumatologists need to match patient’s health literacy, says study
22 May 2023
Comorbidities fewer prior to onset of giant cell arteritis
Comorbidities fewer prior to onset of giant cell arteritis
29 Apr 2023

Patients with giant cell arteritis (GCA) have a lower prevalence of diabetes mellitus as well as median fasting blood glucose (FBG) and body mass index (BMI) up to 5 years prior to diagnosis, according to a study, indicating the influence of metabolic factors on the risk of GCA.

Comorbidities fewer prior to onset of giant cell arteritis
29 Apr 2023
Musculoskeletal surgery not uncommon in psoriatic arthritis
Musculoskeletal surgery not uncommon in psoriatic arthritis
28 Apr 2023

Psoriatic arthritis (PsA) that requires musculoskeletal (MSK) surgery affects more than one in 10 patients (11.8 percent), reveals a study, adding that markers of cumulative disease activity and damage are associated with a greater need for a surgical procedure.

Musculoskeletal surgery not uncommon in psoriatic arthritis
28 Apr 2023
What are the risk factors for relapse after methotrexate dose reduction?
What are the risk factors for relapse after methotrexate dose reduction?
25 Apr 2023

For patients with rheumatoid arthritis, a history of cardiovascular disease, gastrointestinal disease, or liver disease, as well as prior use of nonsteroidal anti-inflammatory drugs can contribute to an increased risk of relapse after methotrexate dose reduction, as suggested in a study.

What are the risk factors for relapse after methotrexate dose reduction?
25 Apr 2023
Telecarers improve treatment, compliance in older hip fracture patients
Telecarers improve treatment, compliance in older hip fracture patients
24 Apr 2023